Sulfonylureas were discovered in 1942, and several have been available since the 1960s. Glyburide is a second-generation sulfonylurea, it works by increasing plasma insulin concentrations.

sulfonylurea (SU) Img Cred: Arch Med Sci. 2015

WHY THE RISK OF HYPOGLYCEMIA?

The biological effect of sulfonylureas often lasts much longer than their plasma half-life, because of receptor interaction and formation of active metabolites, persisting 24 h or more. Moreover, their half-life is prolonged in the presence of renal failure.

REFERENCES

  1. Feldman JM. Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects. Pharmacotherapy. 1985 Mar-Apr;5(2):43-62.
  2. Sola D, Rossi L, Schianca GPC, et al. Sulfonylureas and their use in clinical practice. Archives of Medical Science : AMS. 2015;11(4):840-848. doi:10.5114/aoms.2015.53304.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.